Johnson and Johnson
Janssen sales follow J&J’s downward trend
July 15, 2015Sales and Marketing J&J, JJ, Johnson & Johnson, Johnson and Johnson, financial results, olysio
Strong sales of its new hepatitis C treatment Olysio were not enough to stop a slump in profits at J&J’s …
J&J and Google partner to build surgical robots
March 30, 2015Medical Communications, Sales and Marketing Biogen, Ethicon, J&J, JJ, Johnson and Johnson, MS, google, robots
The medical device subsidiary of Johnson & Johnson Ethicon is to collaborate with Google to build surgical robots and perform …
AbbVie buys Pharmacyclics in $21 billion deal
March 5, 2015Sales and Marketing AbbVie, Humira, Johnson and Johnson, Pharmacyclics, adalimumab, imbruvica
AbbVie has secured Californian biotech Pharmacyclics and beat Johnson & Johnson to gain control of blockbuster blood cancer therapy Imbruvica in …
J&J appoints head of marketing in northern Europe
October 23, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Johnson and Johnson, yana Ignatova
Johnson & Johnson has appointed Yana Ignatova to the position of head of marketing for its northern Europe division. Reporting …
J&J completes $4 billion OCD sale
July 2, 2014Sales and Marketing J&J, JJ, Johnson and Johnson, Ortho-Clinical Diagnostics, carlyle, ocd
Johnson & Johnson has sold its Ortho-Clinical Diagnostics (OCD) business to private equity investor The Carlyle Group for ‘approximately $4 …
Women in the pharma industry
September 3, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Janssen, Johnson and Johnson, adams, women
In the past pharma has been accused of being too male-orientated in both the laboratory and the boardroom. The idea …
Janssen outlines pipeline ambitions
May 24, 2013Research and Development, Sales and Marketing Janssen, Johnson and Johnson, pipeline
Janssen has outlined plans to submit ‘more than ten’ new product filings worldwide in the next four years, along with …
Smoke and fire in J&J Code breach
August 15, 2012Sales and Marketing Champix, J&J, JJ, Johnson and Johnson, PMCPA, Pfizer
Johnson & Johnson has been censured for breaking the ABPI Code of Practice in printed information about its smoking cessation …
TBA contamination prompts Topamax recall
April 18, 2011Manufacturing and Production Johnson and Johnson, recalls
Another Johnson & Johnson business unit has decided to recall medicines because of a mouldy smell thought to be caused …
J&J charged with US manufacturing violations
March 15, 2011Manufacturing and Production J&J, JJ, Johnson and Johnson, McNeil Consumer Healthcare, McNeil Fort Washington, McNeil recall, Motrin recall, manufacturing compliance, pharma manufacturing, recalls
Johnson & Johnson subsidiary McNeil Consumer Healthcare has been officially charged with manufacturing and distributing drugs in violation of federal …
Abbott wins $1.7bn Humira case
February 24, 2011Sales and Marketing Abbott, Abbott Laboratories, Centocor, Johnson and Johnson, Remicade, Simponi, TNF, golimumab, infliximab, rheumatoid arthritis
Abbott has been saved from paying Johnson & Johnson $1.7 billion after a US appeals court quashed a patent dispute …
J&J hepatitis C drug begins phase III trials
February 23, 2011Research and Development J&J, JJ, Johnson and Johnson, TMC435, Tibotec, hepatitis, hepatitis C
Johnson & Johnson has begun late stage trials of hepatitis C drug TMC435 as a first line treatment for the …
J&J posts negative growth as pharma sales stall
January 26, 2011Sales and Marketing 2010 pharma results, J&J, JJ, Johnson and Johnson, Remicade, Risperdal Consta
Falling fourth quarter sales of Risperdal Consta and Remicade capped a year to forget for Johnson and Johnson. The company’s …
Latest content
Five Facts about cardiovascular disease
